Jupiter Neurosciences stock rallies 37% following $11M IPO
Hawkinsight
2024-12-04 09:04:54
2.21W
mapo
- Jupiter Neurosciences (JUNS) shares closed 37% higher following the company's $11M initial public offering on Tuesday.
- The Florida-based drug developer said it offered 2.75M shares priced at $4 per share, raising around $11M.
- Shares of the company began trading on
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
